Skip to main content

Advertisement

SpringerLink
Log in

Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review

  • Review
  • Published:
Infection Aims and scope Submit manuscript

Abstract

We report three cases of external ventricular derivation infections caused by multidrug-resistant Gram-negative rods and treated successfully with intraventricular colistin. The intrathecal or intraventricular use of colistin have been reported in more than 100 cases without any consensus on dosage, duration and type (monotherapy or combination therapy) of treatment. Based on our comprehensive review of the relevant literature relating to both clinical and pharmacokinetic data, we conclude that the intrathecal/intraventricular administration of colistin is a safe and effective option to treat central nervous system infections caused by multidrug-resistant Gram-negative bacteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jantzen JP. Prevention and treatment of intracranial hypertension. Best Pract Res Clin Anaesthesiol. 2007;21:517–38.

    Article  PubMed  Google Scholar 

  2. Gutiérrez-González R, Boto GR, Pérez-Zamarrón A. Cerebrospinal fluid diversion devices and infection. A comprehensive review. Eur J Clin Microbiol Infect Dis. 2012;31:889–97.

    Article  PubMed  Google Scholar 

  3. Kim JH, Desai NS, Ricci J, Stieg PE, Rosengart AJ, Härtl R, Fraser JF. Factors contributing to ventriculostomy infection. World Neurosurg. 2012;77:135–40.

    Article  PubMed  Google Scholar 

  4. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K. EPIC II group of investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–9.

    Article  PubMed  CAS  Google Scholar 

  5. Stenehjem E, Armstrong WS. Central nervous system device infections. Infect Dis Clin North Am. 2012;26:89–110.

    Article  PubMed  Google Scholar 

  6. Camacho EF, Boszczowski I, Basso M, Jeng BC, Freire MP, Guimarães T, Teixeira MJ, Costa SF. Infection rate and risk factors associated with infections related to external ventricular drain. Infection. 2011;39(1):47–51.

    Article  PubMed  CAS  Google Scholar 

  7. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis. 2005;40:1333–41.

    Article  PubMed  CAS  Google Scholar 

  8. Price DJ, Sleigh JD. Klebsiella meningitis—report of nine cases. J Neurol Neurosurg Psychiatry. 1972;35:903–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. Kaplan SL, Patrick CC. Cefotaxime and aminoglycoside treatment of meningitis caused by Gram-negative enteric organisms. Pediatr Infect Dis J. 1990;9:810–4.

    Article  PubMed  CAS  Google Scholar 

  10. Fernandez-Viladrich P, Corbella X, Corral L, Tubau F, Mateu A. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin Infect Dis. 1999;28:916–7.

    Article  PubMed  CAS  Google Scholar 

  11. Vasen W, Desmery P, Ilutovich S, Di Martino A. Intrathecal use of colistin. J Clin Microbiol. 2000;38:3523.

    PubMed  CAS  PubMed Central  Google Scholar 

  12. Benifla M, Zucker G, Cohen A, Alkan M. Successful treatment of acinetobacter meningitis with intrathecal polymyxin E. J Antimicrob Chemother. 2004;54:290–2.

    Article  PubMed  CAS  Google Scholar 

  13. Quinn AL, Parada JP, Belmares J, O’Keefe JP. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection. Ann Pharmacother. 2005;39:949–52.

    Article  PubMed  Google Scholar 

  14. Suárez Fernández C, Fernández-Viladrich P, Tubau F, Corral L, Mateu A. Intrathecal colistin treatment of central nervous system infections due to multi-resistant Acinetobacter baumannii. In: Program and Abstracts of 15th European Congress of Clinical Microbiology and Infectious Diseases. Abstract number 1134_02_277. Copenhagen

  15. Gump WC, Walsh JW. Intrathecal colistin for treatment of highly resistant pseudomonas ventriculitis. case report and review of the literature. J Neurosurg. 2005;102:915.

    Article  PubMed  Google Scholar 

  16. Kasiakou SK, Rafailidis PI, Liaropoulos K, Falagas ME. Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin. J Infect. 2005;50:348–52.

    Article  PubMed  Google Scholar 

  17. Bukhary Z, Mahmood W, Al-Khani A, Al-Abdely HM. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin. Saudi Med J. 2005;26:656–8.

    PubMed  Google Scholar 

  18. Sueke H, Marsh H, Dhital A. Using intrathecal colistin for multidrug resistant shunt infection. Br J Neurosurg. 2005;19:51–2.

    Article  PubMed  CAS  Google Scholar 

  19. Berlana D, Llop JM, Fort E, Badia MB, Jódar R. Use of colistin in the treatment of multiple-drug-resistant Gram-negative infections. Am J Health Syst Pharm. 2005;62:39–47.

    PubMed  CAS  Google Scholar 

  20. Charra B, Hachimi A, Benslama A, Motaouakkil S. Intrathecal use of colistin. Ann Fr Anesth Reanim. 2006;25:215.

    Article  PubMed  CAS  Google Scholar 

  21. Karakitsos D, Paramythiotou E, Samonis G, Karabinis A. Is intraventricular colistin an effective and safe treatment for post-surgical ventriculitis in the intensive care unit? Acta Anaesthesiol Scand. 2006;50:1309–10.

    Article  PubMed  CAS  Google Scholar 

  22. Yagmur R, Esen F. Intrathecal colistin for treatment of Pseudomonas aeruginosa ventriculitis: report of a case with successful outcome. Crit Care. 2006;10:428.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ng J, Gosbell IB, Kelly JA, Boyle MJ, Ferguson JK. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother. 2006;58:1078–81.

    Article  PubMed  CAS  Google Scholar 

  24. Al Shirawi N, Memish ZA, Cherfan A, Al Shimemeri A. Post-neurosurgical meningitis due to multidrug-resistant Acinetobacter baumanii treated with intrathecal colistin: case report and review of the literature. J Chemother. 2006;18:554–8.

    Article  PubMed  CAS  Google Scholar 

  25. Motaouakkil S, Charra B, Hachimi A, Nejmi H, Benslama A, Elmdaghri N, Belabbes H, Benbachir M. Colistin and rifampin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J Infect. 2006;53:274–8.

    Article  PubMed  Google Scholar 

  26. Schina M, Spyridi E, Daoudakis M, Mertzanos E, Korfias S. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin. Int J Infect Dis. 2006;10:178–9.

    Article  PubMed  Google Scholar 

  27. Metan G, Alp E, Aygen B, Sumerkan B. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother. 2007;60:197–9.

    Article  PubMed  CAS  Google Scholar 

  28. Enfanto CM, Shin S. Treatment with intrathecal colistin of a resistant extended-spectrum [beta]-lactamase-producing Klebsiella pneumoniae in the cerebrospinal fluid. Infect Dis Clin Pract. 2007;15:274–7.

    Article  Google Scholar 

  29. Ho YH, Wang LS, Chao HJ, Chang KC, Su CF. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Microbiol Immunol Infect. 2007;40:537–40.

    PubMed  CAS  Google Scholar 

  30. Paramythiotou E, Karakitsos D, Aggelopoulou H, Sioutos P, Samonis G, Karabinis A. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas. Med Mal Infect. 2007;37:124–5.

    Article  PubMed  CAS  Google Scholar 

  31. Lee CH, Tang YF, Su LH, Chien CC, Liu JW. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia. Microb Drug Resist. 2008;14:233–7.

    Article  PubMed  CAS  Google Scholar 

  32. Rodríguez Guardado A, Blanco A, Asensi V, Pérez F, Rial JC, Pintado V, Bustillo E, Lantero M, Tenza E, Alvarez M, Maradona JA, Cartón JA. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother. 2008;61:908–13.

    Article  PubMed  Google Scholar 

  33. Hachimi A, Charra B, Benslama A, Motaouakkil S. Intrathecal use of amikacin and colistin. Ann Fr Anesth Reanim. 2008;27:113–4.

    Article  PubMed  CAS  Google Scholar 

  34. Rodriguez CH, Bombicino K, Granados G, Nastro M, Vay C, Famiglietti A. Selection of colistin-resistant Acinetobacter baumannii isolates in post neurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin. Diagn Microbiol Infect Dis. 2009;65:188–91.

    Article  PubMed  Google Scholar 

  35. López-Alvarez B, Martín-Láez R, Fariñas MC, Paternina-Vidal B, García-Palomo JD, Vázquez-Barquero A. Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin. Acta Neurochir (Wien). 2009;151:1465–72.

    Article  Google Scholar 

  36. Dalgic N, Ceylan Y, Sancar M, Telhan L, Kafadar I, Cavusoglu H, Ceylan O, Hasim O. Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin. Ann Trop Paediatr. 2009;29:141–7.

    Article  PubMed  CAS  Google Scholar 

  37. Baiocchi M, Catena V, Zago S, Badolati L, Baccarin M. Intrathecal colistin for treatment of multidrug resistant (MDR) Pseudomonas aeruginosa after eurosurgical ventriculitis. Infez Med. 2010;18:182–6.

    PubMed  Google Scholar 

  38. De Pascale G, Pompucci A, Maviglia R, Spanu T, Bello G, Mangiola A, Scoppettuolo G. Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin. Minerva Anestesiol. 2010;76:957–60.

    PubMed  Google Scholar 

  39. Khawcharoenporn T, Apisarnthanarak A, Mundy LM. Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review. Clin Microbiol Infect. 2010;16:888–94.

    Article  PubMed  CAS  Google Scholar 

  40. Cascio A, Conti A, Sinardi L, Iaria C, Angileri FF, Stassi G, David T, Versaci A, Iaria M, David A. Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int J Infect Dis. 2010;14:e572–9.

    Article  PubMed  Google Scholar 

  41. Kim K, Kang HS, Sohn CH, Oh BM. Cauda equina syndrome misdiagnosed as aggravated hydrocephalus: neurological complication of intrathecal colistin in post-surgical meningitis. Acta Neurochir (Wien). 2011;153:425–7.

    Article  Google Scholar 

  42. Ozdemir H, Tapisiz A, Ciftçi E, Ince E, Mokhtari H, Güriz H, Aysev AD, Doğru U. Successful treatment of three children with post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis. Infection. 2010;38:241–4.

    Article  PubMed  CAS  Google Scholar 

  43. Razmkon A, Mehrafshan A, Bakhtazad A. Management of post-neurosurgical Acinetobacter infections: experiences obtained during an outbreak. Acta Neurochir (Wien). 2011;153:435–6.

    Article  Google Scholar 

  44. Patel JA, Pacheco SM, Postelnick M, Sutton S. Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis. Am J Health Syst Pharm. 2011;68:1527–31.

    Article  PubMed  CAS  Google Scholar 

  45. Saleem AF, Shah MS, Shaikh AS, Mir F, Zaidi AK. Acinetobacter species meningitis in children: a case series from Karachi. Pak J Infect Dev Ctries. 2011;5:809–14.

    Google Scholar 

  46. Alaoui SY, Nejmi SE, Chakir AA, Hmamouchi B, Chlilek A. Intraventricular colistin use in neonatal meningitis caused by Acinetobacter baumanii. Ann Fr Anesth Reanim. 2011;30:854–5.

    Article  PubMed  CAS  Google Scholar 

  47. Wang JH, Lin PC, Chou CH, Ho CM, Lin KH, Tsai CT, Wang JH, Chi CY, Ho MW. Intraventricular antimicrobial therapy in postneurosurgical Gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study. J Microbiol Immunol Infect. 2012. doi:10.1016/j.jmii.2012.08.028.

  48. Imberti R, Cusato M, Accetta G, Marinò V, Procaccio F, Del Gaudio A, Iotti GA, Regazzi M. Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate. Antimicrob Agents Chemother. 2012;56:4416–21.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  49. Ziaka M, Markantonis SL, Fousteri M, Zygoulis P, Panidis D, Karvouniaris M, Makris D, Zakynthinos E. Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Antimicrob Agents Chemother. 2013;57:1938–40.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  50. Karaiskos I, Galani L, Baziaka F, Katsouda E, Ioannidis I, Andreou A, Paskalis H, Giamarellou H. Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. Int J Antimicrob Agents. 2013;41:480–3.

    Article  PubMed  CAS  Google Scholar 

  51. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267–84.

    Article  PubMed  Google Scholar 

  52. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, Losito AR, Tedeschi S, Cauda R, Bassetti M. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55:943–50.

    Article  PubMed  CAS  Google Scholar 

  53. Liang W, Liu XF, Huang J, Zhu DM, Li J, Zhang J. Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients. BMC Infect Dis. 2011;27:109.

    Article  Google Scholar 

  54. Tan TY, Lim TP, Lee WH, Sasikala S, Hsu LY, Kwa AL. In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and E test methods. Antimicrob Agents Chemother. 2011;55:436–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  55. Tascini C, Gemignani G, Ferranti S, Tagliaferri E, Leonildi A, Lucarini A, Menichetti F. Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections. J Chemother. 2004;16:282–7.

    Article  PubMed  CAS  Google Scholar 

  56. Tascini C, Tagliaferri E, Giani T, Leonildi A, Flammini S, Casini B, Lewis R, Ferranti S, Rossolini GM, Menichetti F. Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2013;57:3990–3.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  57. Jiménez-Mejías ME, Pichardo-Guerrero C, Márquez-Rivas FJ, Martín-Lozano D, Prados T, Pachón J. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis. 2002;21:212–4.

    Article  PubMed  Google Scholar 

  58. Plachouras D, Karvanen M, Friberg LE, Papadomichelakis E, Antoniadou A, Tsangaris I, Karaiskos I, Poulakou G, Kontopidou F, Armaganidis A, Cars O, Giamarellou H. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother. 2009;53:3430–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  59. Everett ED, Strausbaugh LJ. Antimicrobial agents and the central nervous system. Neurosurgery. 1980;6:691–714.

    Article  PubMed  CAS  Google Scholar 

  60. Jiménez-Mejías ME, Becerril B, Márquez-Rivas FJ, Pichardo C, Cuberos L, Pachón J. Successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with intravenous colistin sulfomethate sodium. Eur J Clin Microbiol Infect Dis. 2000;19:970–1.

    Article  PubMed  Google Scholar 

  61. Antachopoulos C, Karvanen M, Iosifidis E, Jansson B, Plachouras D, Cars O, Roilides E. Serum and cerebrospinal fluid levels of colistin in pediatric patients. Antimicrob Agents Chemother. 2010;54:3985–7.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  62. Markantonis SL, Markou N, Fousteri M, Sakellaridis N, Karatzas S, Alamanos I, Dimopoulou E, Baltopoulos G. Penetration of colistin into cerebrospinal fluid. Antimicrob Agents Chemother. 2009;53:4907–10.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

  1. Infectious Diseases Department, University Hospital “Maggiore della Carità”, Novara, Italy

    O. Bargiacchi, A. Rossati, D. Brustia, R. Brondolo, F. Rosa & P. L. Garavelli

  2. Neurosurgery Department, University Hospital “Maggiore della Carità”, Novara, Italy

    P. Car

  3. Department of Medical Sciences, Infectious Diseases, University of Turin, Turin, Italy

    F. G. De Rosa

Authors
  1. O. Bargiacchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Rossati
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Car
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Brustia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Brondolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Rosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. L. Garavelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F. G. De Rosa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. Bargiacchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bargiacchi, O., Rossati, A., Car, P. et al. Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review. Infection 42, 801–809 (2014). https://doi.org/10.1007/s15010-014-0618-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-014-0618-0

Keywords

Search

Navigation